MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 02.08.2023
Conformis Kurzfristige Verbindlichkeiten 2011-2026 | CFMS
Kurzfristige Verbindlichkeiten Jährlich Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 M | 18 M | 30.9 M | 17.9 M | 11.4 M | 12.9 M | 14.3 M | 13.1 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.9 M | 11.4 M | 16.6 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
129 M | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
153 M | $ 20.67 | -1.76 % | $ 2.95 B | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.52 | 0.57 % | $ 122 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.91 | -5.21 % | $ 640 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
6.4 B | $ 94.77 | -0.63 % | $ 139 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 304.72 | 0.42 % | $ 8.6 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 27.78 | -4.4 % | $ 235 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 47.97 | 1.83 % | $ 7.15 K | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Abbott Laboratories
ABT
|
14.2 B | $ 124.11 | -0.94 % | $ 216 B | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.31 | 0.61 % | $ 123 M |  France |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
IRadimed Corporation
IRMD
|
8.51 M | $ 95.52 | -1.81 % | $ 1.21 B | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
69.9 M | $ 14.91 | 1.46 % | $ 1.18 B | Israel |
 |
LivaNova PLC
LIVN
|
392 M | $ 60.9 | -1.02 % | $ 3.3 B |  Britain |
|
LENSAR
LNSR
|
15 M | $ 11.68 | 0.43 % | $ 135 M | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 156.64 | 0.31 % | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
193 M | $ 0.85 | 3.09 % | $ 87.4 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
10.4 M | $ 14.01 | 2.41 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.52 | -0.24 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
30.6 M | $ 30.97 | -5.38 % | $ 1.37 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.18 | 3.51 % | $ 19 M | USA |
 |
CONMED Corporation
CNMD
|
278 M | $ 40.83 | 0.62 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
34 M | $ 17.7 | -0.32 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
856 M | $ 87.03 | -0.39 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 12.02 | -3.22 % | $ 926 M | USA |
 |
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M | USA |
 |
Myomo
MYO
|
3.6 M | $ 0.96 | 3.31 % | $ 6.77 M | USA |